UA107687C2 - Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен. - Google Patents

Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен.

Info

Publication number
UA107687C2
UA107687C2 UAA201207518A UAA201207518A UA107687C2 UA 107687 C2 UA107687 C2 UA 107687C2 UA A201207518 A UAA201207518 A UA A201207518A UA A201207518 A UAA201207518 A UA A201207518A UA 107687 C2 UA107687 C2 UA 107687C2
Authority
UA
Ukraine
Prior art keywords
carnitine
diosmlne
troxerutine
hesperidine
propionyl
Prior art date
Application number
UAA201207518A
Other languages
English (en)
Ukrainian (uk)
Inventor
Мохамед Ашраф Вірмані
Алеардо Коверек
Original Assignee
Сігма-Тау Індустріє Фармасьютіке Ріуніте С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сігма-Тау Індустріє Фармасьютіке Ріуніте С.П.А. filed Critical Сігма-Тау Індустріє Фармасьютіке Ріуніте С.П.А.
Publication of UA107687C2 publication Critical patent/UA107687C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Комбинированная композиция, которая в качестве активных ингредиентов содержит L-карнитин или пропионил-L-карнитин, троксерутин, диосмин и гесперидин, которая подходит для предотвращения и/или лечения хронических заболеваний вен.
UAA201207518A 2010-02-02 2011-02-07 Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен. UA107687C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10152363A EP2353596A1 (en) 2010-02-02 2010-02-02 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
PCT/IB2011/000200 WO2011095882A1 (en) 2010-02-02 2011-02-07 Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency

Publications (1)

Publication Number Publication Date
UA107687C2 true UA107687C2 (ru) 2015-02-10

Family

ID=41820403

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201207518A UA107687C2 (ru) 2010-02-02 2011-02-07 Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен.

Country Status (20)

Country Link
US (3) US20110189152A1 (ru)
EP (2) EP2353596A1 (ru)
CN (1) CN102791263B (ru)
AU (1) AU2011212153B2 (ru)
BR (1) BR112012019351A2 (ru)
CO (1) CO6551731A2 (ru)
DK (1) DK2531189T3 (ru)
EA (1) EA021107B1 (ru)
ES (1) ES2487647T3 (ru)
IL (1) IL221273A (ru)
MX (1) MX2012008890A (ru)
NZ (1) NZ600695A (ru)
PE (1) PE20121700A1 (ru)
PL (1) PL2531189T3 (ru)
PT (1) PT2531189E (ru)
RS (1) RS53515B1 (ru)
SG (1) SG182323A1 (ru)
SI (1) SI2531189T1 (ru)
UA (1) UA107687C2 (ru)
WO (1) WO2011095882A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2999934B1 (fr) * 2012-12-21 2015-02-20 Servier Lab Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoique et de la gomme xanthane
CA2931109C (en) * 2013-12-05 2021-08-24 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition useful for promoting female fertility
FR3019820B1 (fr) * 2014-04-15 2017-07-21 Peter Weyts Composes de type flavonoides pour leur utilisation dans le traitement d'une pathologie du pied d'un mammifere ongule-composition pharmaceutique associee
CN104605451A (zh) * 2015-01-31 2015-05-13 丁年生 一种防止毛细血管出血的玫瑰花饮料及其制备方法
RU2704976C2 (ru) * 2017-05-10 2019-11-01 Общество с ограниченной ответственностью "Трейдсервис" Флеботропная комбинированная фармацевтическая композиция
RU2705794C1 (ru) * 2018-09-26 2019-11-12 Общество с ограниченной ответственностью "Трейдсервис" Комбинированная мягкая лекарственная форма для лечения геморроидальных заболеваний
RU2689409C1 (ru) * 2018-11-21 2019-05-28 Общество с ограниченной ответственностью "Трейдсервис" Комбинированная мягкая лекарственная форма диосмина и троксерутина
IT202000003122A1 (it) * 2020-02-17 2021-08-17 Apharm Srl Associazione di principi attivi e loro uso nel trattamento e/o nella prevenzione della insufficienza venosa
HUP2100299A1 (hu) 2021-08-19 2023-02-28 Keri Pharma Hungary Kft Új gyógyászati kombináció alkalmazása krónikus vénás elégtelenség kezelésére

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1156852B (it) 1978-07-10 1987-02-04 Sigma Tau Ind Farmaceuti Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni
IT1206954B (it) 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
JP2669146B2 (ja) 1990-11-26 1997-10-27 富士電機株式会社 半導体素子の保護用ヒューズ
FR2710844B1 (fr) * 1993-10-07 1995-12-29 Bidel Christian Georges Composition pour le traitement ou la prévention de l'herpès.
PT793962E (pt) 1996-03-04 2000-05-31 Sigma Tau Ind Farmaceuti Medicamento contendo um derivado da carnitina para tratamento de arteriosclerose obliterans
US5949786A (en) * 1996-08-15 1999-09-07 3Com Corporation Stochastic circuit identification in a multi-protocol network switch
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
ITRM20020055A1 (it) * 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti
DE10240923A1 (de) * 2002-09-02 2004-03-04 Merck Patent Gmbh Flavonoid-Derivate zur Ekzem-Behandlung
ITRM20030178A1 (it) 2003-04-17 2004-10-18 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
AT501682A1 (de) * 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
US20070087975A1 (en) 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
MX2007011002A (es) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica.

Also Published As

Publication number Publication date
DK2531189T3 (da) 2014-09-01
CO6551731A2 (es) 2012-10-31
IL221273A (en) 2015-07-30
IL221273A0 (en) 2012-10-31
EP2353596A1 (en) 2011-08-10
EA201200786A1 (ru) 2013-01-30
US9457037B2 (en) 2016-10-04
ES2487647T3 (es) 2014-08-22
US20140018310A1 (en) 2014-01-16
EP2531189B1 (en) 2014-06-11
EP2531189A1 (en) 2012-12-12
US20110189152A1 (en) 2011-08-04
AU2011212153A1 (en) 2012-07-05
SG182323A1 (en) 2012-08-30
CN102791263B (zh) 2016-10-12
MX2012008890A (es) 2012-08-31
WO2011095882A1 (en) 2011-08-11
BR112012019351A2 (pt) 2017-06-27
PT2531189E (pt) 2014-08-25
US20130005670A1 (en) 2013-01-03
EA021107B1 (ru) 2015-04-30
SI2531189T1 (sl) 2014-09-30
WO2011095882A8 (en) 2012-08-02
PE20121700A1 (es) 2012-12-22
CN102791263A (zh) 2012-11-21
NZ600695A (en) 2014-03-28
PL2531189T3 (pl) 2014-10-31
AU2011212153B2 (en) 2016-08-04
RS53515B1 (en) 2015-02-27

Similar Documents

Publication Publication Date Title
UA107687C2 (ru) Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен.
WO2012083048A3 (en) Anti-viral compounds
WO2012083053A3 (en) Anti-viral compounds
WO2010087964A3 (en) Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
WO2009089494A3 (en) Pharmaceutical compositions
WO2012125544A3 (en) Necroptosis inhibitors and methods of use therefor
IN2012DN00624A (ru)
MX2011011178A (es) Compuesto de diaciletilendiamina.
TN2011000482A1 (en) Organic compounds and their uses
IN2012DN01434A (ru)
WO2012083058A3 (en) Anti-viral compounds
WO2011076367A3 (en) Synergistic antiviral composition and use thereof
WO2011042902A3 (en) Microcapsules comprising benzoyl peroxide and topical compositions comprising them
WO2012162580A3 (en) Anti-viral compounds
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2012162578A3 (en) Anti-viral compounds
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
GB201020119D0 (en) Pharamaceutical and other compositions, e.g. for the skin, comprising emulsifying ointment and water
WO2012065028A3 (en) Substituted tetracyclines
MY182607A (en) Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency
WO2012064557A3 (en) Deodorizing compositions
NZ613887A (en) Antimicrobial activity enhancing agent
WO2010142981A3 (en) Composition and uses thereof
WO2014053625A3 (fr) Propionibacterium freudenreichii en tant qu'actif contre les désordres cutanés
WO2012134167A3 (ko) 비파엽 추출물을 포함하는 폐암 치료용 조성물 및 건강 기능성 식품